Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Hydrocarbon doai
Patent
1993-12-13
1995-10-03
Nutter, Nathan M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Hydrocarbon doai
514766, 514783, 514908, A61K 31015
Patent
active
054552800
ABSTRACT:
According to the present invention, there is provided a method for treating chronic lymphocytic leukemia (CLL) in a mammal. Beta-carotene is administered to the mammal in CLL therapeutically effective amounts. The invention also contemplates a method for treating T-cell chronic lymphocytic leukemia (T-CLL). T-CLL therapeutically effective amounts of beta-carotene are administered. In further embodiment, a method for lowering or maintaining the level of white blood cells in a mammal having chronic lymphocytic leukemia is provided. White blood cell therapeutically effective amounts of beta-carotene are administered to the mammal.
REFERENCES:
patent: 5008295 (1991-04-01), Nishino et al.
Harinder S. Garewal, et al. (1992) Cancer Epidemiology, Biomarkers & Prevention, vol. 1, pp. 155-159.
(Editorial) (1992) Annals of Internal Medicine, vol. 1, 117, No. 4, pp. 338-340.
Kenneth A. Foon, et al. (1992) LEUKEMIA, 6 Suppl. 4:26-32. pp. 26-32.
Dirck L. Dillehay, et al. (1989) Cancer Research, vol. 49, pp. 44-50.
I. Blazsek, et al. (1991) Biomed & Pharmacother, vol. 45, pp. 169-177.
Josephia R. F. Muindi, et al. (1992) Cancer Research, vol. 52, pp. 2138-2142.
John S. Bertram, et al. (1987) Cancer Research, vol. 47, pp. 3012-3031.
Gonul Hicsonmez, et al. (1991) Leukemia Research, vol. 15, No. 7, pp. 537-541.
P. Fenaux, et al. (1992) LEUKEMIA, vol. 6, Suppl. 1, pp. 64-66.
Sylvie Castaigne, et al. (1990) Blood, vol. 76, No. 9, pp. 1704-1709.
Raymond P. Warrell, Jr., et al. (1990) New England Journal of Medicine, vol. 324, pp. 1385-1393.
Stanley R. Frankel, et al. (1992) Annals of Internal Medicine, vol. 117, No. 4, pp. 292-296.
Laurence Detourmignies, et al. (1992) Journal of Clinical Oncology, vol. 10, No. 9, pp. 1430-1435.
B. A. Bell, et al. (1991) Journal of Immunotherapy, vol. 10, pp. 77-83.
Achary B. Kramer, et al., (1991) CANCER, vol. 67, No. 6, pp. 1484-1486.
Harry W. Findley, Jr., et al. (1984) Experimental Hematology, vol. 12, pp. 768-773.
Edo Hoting, et al. (1988) CANCER, vol. 62, No. 6, pp. 1044-1048.
Stephen J. Hoffman, et al. (1988) American Journal of Hematology, vol. 28, pp. 124-127.
Attilio Roveli, et al. (1992) Journal of Clinical Oncology, vol. 10, No. 9. pp. 1413-1418.
Mikio Furuse, et al. (1992) Cellular Immunology, vol. 143, pp. 298-309.
Arnold S. Freedman (1990) Hematology/Oncology Clinics of North America, vol. 4, No. 2, pp. 405-429.
Tin Han, et al. (1990) Hematology/Oncology Clinics of North America, vol. 4, No. 2, pp. 431-445 441-455.
Richard M. Stone (1990) Hematology/Oncology Clinics of North America, vol. 4, No. 2, p. 457.
Nancy Berliner (1990) Hematology/Oncology Clinics of North America, vol. 4, No. 2, pp. 473-487.
Michael J. Keating et al. (1992) LEUKEMIA, vol. 6, Supplement 4, pp. 140-141.
Ciril Rozman, et al. (1992) LEUKEMIA, vol. 6, Supplement 4, pp. 137-139.
Richard I. Edelson, M.D. (1992) Yale University/Glaxo Dermatology Lectureship Series in Dermatology, Lecture, pp. 4-16.
R. A. Krance, et al. (1992) LEUKEMIA, vol. 6, No. 4, pp. 251-255.
David F. Claxton, et al. (1992) BLOOD, vol. 80, No. 3, pp. 582-586.
S. Waxman, et al. (1992) Biomed & Pharmacother, vol. 46, pp. 183-192.
Mun-Fai Leung et al. (1992) Leukemia Research, vol. 16, No. 9, pp. 929-935.
J. Brice Weinberg, et al. (1992) BLOOD, vol. 79, No. 12, pp. 3337-3343.
Donald Pinkel, et al. (1992) LEUKEMIA, vol. 6, Supplement 2, pp. 127-131.
Olalekan Odeleye, et al. (1992) Life Sciences, vol. 51, pp. 129-134.
Seitetsu Sato, et al. (1992) Anticancer Reserach, vol. 12, pp. 371-376.
Masaaki Inaba, et al. (1992) Archives of Biochemistry and Biophysis, vol. 293, No. 1, pp. 181-186.
Martin S. Tallman et al. (1992) BLOOD, vol. 79, No. 3 pp. 543-553.
N. Takeichi, et al. An LPS-Resistant Sublne of Rat Myelomonocytic Leukemia Acquires Organ-Affinity, pp. 328-333.
Nancy L. Oliveira, et al., (1992) BLOOD, vol. 79, No. 3, pp. 627-633.
Craig Moskowitz, et al. (1992) American Journal of Hematology, vol. 39, pp. 102-107.
Robert Hast, et al. (1992) Leukemia Research, vol. 16, No. 1, pp. 95-100.
James R. Flanagan, et al. (1992) Molecular and Cellular Biology, vol. 12, No. 1, pp. 38"44.
Kun-Sang Chang, et al. (1992) Molecular and Cellular Biology, vol. 12, No. 2, pp. 800-810.
Kun-Sang Chang, et al. (1992) BLOOD, vol. 79, No. 3, pp. 554-558.
Daniel. W. Nebert, et al. (1979) Biochemical Pharmacology, vol 27, pp. 149-151.
Maria L. Duran-Reynals, et al. (1978) The Journal of Experimental Medicine, vol. 147, pp. 459-469.
Fabien Guidez, et al. (1991) LEUKEMIA, vol. 5, No. 8, pp. 699-703.
Daniel S. Cowen, et al. (1991) Journal of Leukocyte Biology, vol. 50, pp. 109-122.
A. Geurts van Kessel, et al. (1991) Human Genetics, vol. 87, pp. 201-204.
S. Smith (1971) Am. Assoc. Cancer Res., vol. 12, p. 85.
Tsuyoshi Nakamaki, et al. (1990) Leukemia Research, vol. 14, No. 9, pp. 785-794.
Victoria L. Stevens, et al. (1990) Cancer Research, vol. 50, pp. 222-226.
Raymond J. Monnat, Jr. (1989) Cancer Research, vol. 49, pp. 81-87.
Ludwik Groos (1988) CANCER, vol. 62, No. 8, pp. 1463-1465.
Haruhiko Ohashi, et al. (1992) LEUKEMIA. vol. 6, No. 8, pp. 859-862.
S. Tohda, et al. (1992) LEUKEMIA, vol. 6, No. 7, pp. 656-661.
Jose R. Perez, et al. (1992) Journal of Cellular Biochemistry, vol. 50, pp. 26-34.
Jianming Li, et al. (1992) Leukemia Research, vol. 16, No. 6/7, pp. 571-576.
Eric K-W. Hui, et al. (1992) Life Sciences, vol. 51, pp. 415-422.
Eric K-W. Hui, et al. (992) Experimental Hematology, vol. 20, pp. 454-461.
Piotr Pierzchalsi, et al. (1992) FEBS 10732, vol. 298, No. 2,3, pp. 165-168.
S. Tohda, et al. (1991) LEUKEMIA, vol. 5, No. 11, pp. 951-957.
N. Takahashi et al., Retinoic Acid Acylation, pp. 255-264.
Josephia Muindi, et al. (1992) BLOOD, vol. 79, No. 2, pp. 299-303.
V. Santini, et al. (1991) Leukemia Research, vol. 15, No. 5, pp. 341-350.
Editorial (1991) Leukemia Research, vol. 15, No. 8, pp. 655-657.
Peter H. Wiernik, et al. (1991) LEUKEMIA, vol. 5, No. 6, pp. 504-509.
Kosei Takeuchi, et al. (1991) Biochemical and Biophysical Research Communications, vol. 178, No. 1 pp. 263-268.
Kent A. Robertson, et al. (1991) BLOOD, vol. 77, No. 2, pp. 340-347.
Alam et al. (1990) Nutrition and Cancer, vol. 14, No. 2, pp. 111-116.
Akiko Sakashita, et al. (1991) LEUKEMIA, vol. 5, No. 1, pp. 26-31.
Yuhei Hamasaki, et al. (1991) Biochimica et Biophysica Acta, vol. 1082, pp. 126-129.
Carlo Aul, et al. (1992) Leukemia Research, vol. 16, No. 3, pp. 207-215.
Theodore R. Breitman, et al. (1990) Cancer Research, vol. 50, pp. 6268-6273.
Tsuyoshi Nakamaki, et al. (1989) Jpn. J. Cancer Res., vol. 80, pp. 1077-1082.
Steven J. Collins, et al. (1990) Molecular and Cellular Biology, vol. 10, No. 5, pp. 2154-2163.
Chi-Kuan Ho, et al. (1989) Differentiation, vol. 40, pp. 70-75.
F. Serri, et al. (1990) Current Problems in Dermatology, vol. 19, pp. 252-257.
Kun-Sang Chang, et al. (1991) LEUKEMIA, vol. 5, No. 3, pp. 200-204.
Takehiko Nakamura, et al. (1988) Eur. J. Haematol, vol. 41, pp. 258-266.
Robert E. Gallagher, et al. (1989) LEUKEMIA, vol. 3, No. 11, pp. 789-795.
Xingzhong Wu, et al. (1989) Leukemia Research, vol. 13, No. 10, pp. 869-874.
Masue Imaizumi, et al. (1988) Cancer Research, vol. 48, No. 13, pp. 6733-6738.
Wilson H. Miller, Jr., et al. (1992) Proc. Natl. Acad. Sci. USA, vol. 89, pp. 2694-2698.
Degos, L. et al., Saurat J-H (ed): Retinoids: 10 Years On. Basel, Karger, 1991, pp. 121-126.
Cornic, M., et al. (1992) Bull Cancer, vol. 79, pp. 697-704.
Philippe Kastner, et al. (1991) C.R. Soc. Biol., vol. 185, pp. 391-401.
Mokady et al. (1991) Nutrution and Cancer, vol. 15, No. 1, pp. 47-52.
Dimitrov et al. (1990) Chemistry & Biology, pp. 269-277.
Runde et al. (1992) Blood, vol. 79. No. 2, pp. 53-535.
LandOfFree
Treatment of chronic lymphocytic leukemia with beta-carotene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of chronic lymphocytic leukemia with beta-carotene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of chronic lymphocytic leukemia with beta-carotene will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1077870